Silvercrest Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Silvercrest Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-310,070	Closed	-$5.65M	–	873
2021 Q1	$5.65M	Sell	310,070 -575,186	-65%	-$9.56M	0.04%	360
2020 Q4	$10.2M	Buy	885,256 +6,451	+0.7%	+$59K	0.07%	239
2020 Q3	$6.7M	Sell	878,805 -16,746	-2%	-$127K	0.06%	280
2020 Q2	$5.88M	Buy	895,551 +159,408	+22%	+$890K	0.05%	284
2020 Q1	$3.76M	Buy	736,143 +173,411	+31%	+$1.05M	0.04%	327
2019 Q4	$4.32M	Buy	+562,732	New	+$3.28M	0.03%	379

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Silvercrest Asset Management's CDMO Position: Q2 2021 in Review

Silvercrest Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2021, closing a stake of 310,070 shares — an estimated $5.65M sold.

Silvercrest Asset Management first reported a position in CDMO in Q4 2019 and held it in 6 quarters. The position peaked at $10.2M in Q4 2020. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2021.

Silvercrest Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Silvercrest Asset Management sold 310,070 Avid Bioservices, Inc. Common Stock shares in Q2 2021, an estimated $5.65M.
Silvercrest Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Silvercrest Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $10.2M in Q4 2020.
172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2021.

Based on Silvercrest Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.